STAMFORD, Conn., and DANVILLE, Pa.– Patients in a study conducted by Purdue Pharma and Geisinger are using wearable health technology frequently and consistently to document pain scores, medications, alternative therapies, sleep and activity, according to a recently-released interim analysis.
“We are encouraged by these interim data and pleased to report that adding wearable health technology to our Multidisciplinary Pain Program has been well received by patients and, furthermore, has increased communication between providers and patients,” said Dr. John Han, director of the department of pain medicine at Geisinger, in a statement. “The integration of wearable health technology augments the assessments conducted in clinic with patient-reported data. The additional data seem to be supporting more robust interactions between doctors, clinic staff and patients compared to what we’ve seen when patients rely on memory to describe their pain between clinic visits.”
The ongoing, prospective, non-randomized, non-blinded trial with historic and concurrent controls will assess the effect of wearable health technology on patient and health system outcomes. Announced last year, the study is designed to assess the effect of the addition of wearable health technology on patient and health system outcomes within a multidisciplinary pain program for patients with chronic pain in the Geisinger health care system.
The wearable health technology under evaluation includes an Apple Watch and iPhone equipped with a pain app, and a customizable provider dashboard to facilitate review of the collected data and discussions with patients. The app and dashboard were designed specifically for this study.
“We’re pleased to see patients benefiting from the technology,” said Thomas Alfieri, director of medical affairs strategic research at Purdue Pharma, in a statement. “We believe there is a strong potential for wearable health technology to be used by patients with chronic pain and other chronic conditions, and this analysis provides important information that will inform the use of such technologies in the future.”